Status Epilepticus: Clinical Trials

2 trials for Status Epilepticus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 32Terminated 2

Follow Status Epilepticus: new trials by email Literature Review of Status Epilepticus trials Research Report on Status Epilepticus

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
Vatiquinone, Placebo - Mitochondrial Diseases, Drug Resistant Epilepsy
Phase 2 / Phase 3TerminatedPTC Therapeutics682020-09-282026-03-31
Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome
Diazepam, Acetazolamide - Landau-Kleffner Syndrome, Status Epilepticus, Electrographic
Phase 2 / Phase 3TerminatedMayo Clinic32016-09-012020-06-11

Narrower conditions

Diffuse Cerebral Sclerosis of Schilder (1)  ·  Drug Resistant Epilepsy (1)  ·  Landau-Kleffner Syndrome (1)  ·  Leigh Disease (1)  ·  MELAS Syndrome (1)  ·  MERRF Syndrome (1)  ·  Mitochondrial Diseases (1)  ·  Mitochondrial encephalopathy (1)  ·  Nerve Degeneration (1)  ·  Pontocerebellar Hypoplasia Type 6 (1)  ·  Seizures (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Epilepsy (2)  ·  Epileptic Syndromes (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Small Vessel Diseases (1)

Interventions

Acetazolamide (1)  ·  Diazepam (1)  ·  alpha-tocotrienol quinone (1)

Sponsors

Mayo Clinic (1)  ·  PTC Therapeutics (1)

Countries

United States (2)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Katherine C. Nickels, M.D. (1)  ·  Vinay Penematsa, MD (1)